Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-01-13 @ 11:40 AM
Study NCT ID:
NCT06694350
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-19
First Post:
2024-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC
Sponsor:
Zhejiang Provincial People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KF20240822
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None